HYPR Stock Overview
A medical device company, provides magnetic resonance imaging (MRI) products in the United States. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Hyperfine, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.02 |
52 Week High | US$1.42 |
52 Week Low | US$0.76 |
Beta | 0.84 |
11 Month Change | 3.03% |
3 Month Change | 0% |
1 Year Change | -15.00% |
33 Year Change | -89.64% |
5 Year Change | n/a |
Change since IPO | -89.81% |
Recent News & Updates
Recent updates
Analysts Are Updating Their Hyperfine, Inc. (NASDAQ:HYPR) Estimates After Its Third-Quarter Results
Nov 15Hyperfine appoints Maria Sainz as President, CEO
Oct 06Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M
Aug 10Hyperfine stock plunges 14% as CEO Dave Scott steps down
Jun 29Hyperfine (NASDAQ:HYPR) Is In A Good Position To Deliver On Growth Plans
Apr 04Hyperfine: MR Imaging In A Swoop
Mar 09Shareholder Returns
HYPR | US Medical Equipment | US Market | |
---|---|---|---|
7D | 15.3% | 1.5% | 2.2% |
1Y | -15.0% | 20.9% | 31.7% |
Return vs Industry: HYPR underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: HYPR underperformed the US Market which returned 31.7% over the past year.
Price Volatility
HYPR volatility | |
---|---|
HYPR Average Weekly Movement | 8.1% |
Medical Equipment Industry Average Movement | 8.1% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HYPR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: HYPR's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 131 | Maria Sainz | hyperfine.io |
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Hyperfine, Inc. Fundamentals Summary
HYPR fundamental statistics | |
---|---|
Market cap | US$74.41m |
Earnings (TTM) | -US$41.01m |
Revenue (TTM) | US$13.26m |
5.6x
P/S Ratio-1.8x
P/E RatioIs HYPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HYPR income statement (TTM) | |
---|---|
Revenue | US$13.26m |
Cost of Revenue | US$7.16m |
Gross Profit | US$6.10m |
Other Expenses | US$47.11m |
Earnings | -US$41.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.56 |
Gross Margin | 46.01% |
Net Profit Margin | -309.42% |
Debt/Equity Ratio | 0% |
How did HYPR perform over the long term?
See historical performance and comparison